Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Brittney Baer"'
Autor:
Katie S. Gatwood, Bhagirathbhai R. Dholaria, Mariana Lucena, Brittney Baer, Bipin N. Savani, Olalekan O. Oluwole
Publikováno v:
eJHaem, Vol 3, Iss S1, Pp 54-60 (2022)
Abstract Adoptive cellular therapy has made a landmark change within the treatment paradigm of several hematologic malignancies, and novel cellular therapy products, such as chimeric antigen receptor T‐cell therapy (CART), have demonstrated impress
Externí odkaz:
https://doaj.org/article/00008ecd51d54b89bab703d8e5bdaba3
Autor:
Temitayo A. Akosile, Bhagirathbhai Dholaria, Nasima Mehraban, Brittney Baer, Nancy Clayton Long, Reena V Jayani, Adetola A. Kassim, Brian G. Engelhardt, Salyka Sengsayadeth, Vivek G. Patel, Shakthi T Bhaskar, Bipin Savani, Dr. Olalekan O. Oluwole
Publikováno v:
Transplantation and Cellular Therapy. 29:S157-S158
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7c97b79969ac0674c85a64e46c435949
https://doi.org/10.1016/s2666-6367(23)00270-1
https://doi.org/10.1016/s2666-6367(23)00270-1
Autor:
Bhagirathbhai Dholaria, Nasima Mehraban, Brittney Baer, Nancy Long, Reena V. Jayani, Michael T. Byrne, Adetola A. Kassim, Brian G. Engelhardt, Bipin N. Savani, Olalekan O. Oluwole
Publikováno v:
British journal of haematologyREFERENCES. 198(6)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1dba227408409bfca8e1104054d5145
https://pubmed.ncbi.nlm.nih.gov/35765247
https://pubmed.ncbi.nlm.nih.gov/35765247
Autor:
Brittney Baer, Katie S. Gatwood, Olalekan O. Oluwole, Bhagirathbhai Dholaria, Mariana Lucena, Bipin N. Savani
Publikováno v:
EJHaem. 3(Suppl 1)
Adoptive cellular therapy has made a landmark change within the treatment paradigm of several hematologic malignancies, and novel cellular therapy products, such as chimeric antigen receptor T-cell therapy (CART), have demonstrated impressive efficac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::baea336c2e8a8be755e70eafb8fada54
https://pubmed.ncbi.nlm.nih.gov/35844300
https://pubmed.ncbi.nlm.nih.gov/35844300
Autor:
Brittney Baer
Publikováno v:
Clinical journal of oncology nursing. 25(3)
Chimeric antigen receptor (CAR) T-cell therapy is an evolving treatment used for hematologic malignancies; it requires specialized nursing care and knowledge. This article discusses updates in the nursing management of CAR T-cell therapies and their
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::deb5d294ac97811c47527928e2825113
https://pubmed.ncbi.nlm.nih.gov/34533518
https://pubmed.ncbi.nlm.nih.gov/34533518
Autor:
Pat Groff, Brittney Baer
Publikováno v:
Clinical Journal of Oncology Nursing. 25:496-496
I have found Clinical Journal of Oncology Nursing (CJON) articles to be enlightening and well written, and I look forward to reading CJON monthly to expand my general cancer care knowledge. I have been a blood and marrow transplantation (BMT) nurse s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22b1a871da5ec262f6376f1eda4a3e44
https://doi.org/10.1188/21.cjon.496
https://doi.org/10.1188/21.cjon.496
Autor:
Channing Vail Dudley, Brittney Baer
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:S380
Topic Significance & Study Purpose/Background/Rationale • With the increase in Immune Effector Cell (IEC) technology in both research and clinical settings, clinicians are challenged with the task of treating acute known adverse events, including c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c8c8c9946b6bb2ee0ef89fc9afabb4fb
https://doi.org/10.1016/j.bbmt.2019.12.171
https://doi.org/10.1016/j.bbmt.2019.12.171
Autor:
Nishitha Reddy, Edwin P. Alyea, Sairah Ahmed, Susheela Madhu, Madan Jagasia, David B. Miklos, Tiffany Hill, Maria Guillermo-Pacheco, Olalekan O. Oluwole, Luciano J. Costa, Laura Dugger, Kelly Chyan, Ted Jackson Miller, Brittney Baer
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:S403-S404
Background Ibrutinib is approved for a variety of B-cell malignancies, including CLL and MCL, and for chronic GVHD (cGVHD), failing ≥ 1 line of systemic therapy. Allogeneic HCT is curative for CLL and MCL, but success is limited due to relapse or G
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e500ee23129a2b87c0fa3c3ee2a6f0d8
https://doi.org/10.1016/j.bbmt.2018.12.819
https://doi.org/10.1016/j.bbmt.2018.12.819
Publikováno v:
Seminars in Oncology Nursing. 35:150931
Objective To discuss current recommendations and resources for nurses to ensure they advocate for patients with cytokine release syndrome (CRS). Data Sources A literature search using key terms: cytokine release syndrome, neurotoxicity, CAR T, advers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c339ab3486bcbcecde099e553ff397a1
https://doi.org/10.1016/j.soncn.2019.08.010
https://doi.org/10.1016/j.soncn.2019.08.010